Toledo, OH – June 12, 2017 Bionix Radiation Therapy has recently signed an agreement to serve as the exclusive distributor of AccuBoost. Adding to the growing portfolio of brachytherapy solutions, Bionix will market AccuBoost, a non-invasive option for breast treatment.

AccuBoost is the simple, non-invasive way to target and deliver partial breast irradiation under real-time mammography image guidance. The conformal dose of AccuBoost is delivered either for the boost portion of Whole Breast Irradiation (WBI), or as a substitute to invasive 5-day APBI procedures. AccuBoost limits unintentional exposure to healthy tissue, eliminates catheter related complications and minimizes unintentional radiation-related toxicity. AccuBoost is a reliable method, with a seamless adoption to practices, increasing the utilization of a facility’s afterloader.

“We are pleased to offer the AccuBoost solution in our portfolio, giving our customers the best tools to help fight breast cancer,” says President, David Hart. “The AccuBoost solution will help us better serve the needs of clinicians”.


About Bionix Radiation Therapy:
Since 1984, Bionix Radiation Therapy has been providing the radiation therapy community with innovative, quality and precise products for external beam radiation therapy, and we are proud to offer our newly expanded portfolio of brachytherapy products. We are dedicated to collaboration with clinicians to create novel approaches for current challenges in radiation oncology. We strive for elegant, simple and effective solutions with patient outcome in mind. Bionix Radiation Therapy is on the forefront of clinical technology. We are taking radical approaches to improve precision and accuracy from the most highly complex cancers that require advanced precision. Our solutions are providing clinicians with the tools they need to treat cancer while we maintain our focus on the fight to end cancer.